Skip to content
healthcare.dev

Clindamycin Phosphate

NDC 45802-263, Clindamycin Phosphate, solution, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-263
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SOLUTION
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA065049
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-263 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLINDAMYCIN PHOSPHATE10 mg/mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]

Package NDCNDC-11Package
45802-263-374580202633760 APPLICATOR in 1 JAR (45802-263-37) / 1 mL in 1 APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e492d645-7d2e-4f8a-a43a-9999456e9f72
  • NADAC price for package 45802026337

    GET /v1/drugs/nadac/45802026337

Use it

Look up 45802-263 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-263 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-263. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.